PostAcute Care and Hospice Provider Data 2017
Ali, GIP ima suprotno dejstvo od GLP-1 kada je u pitanju proizvodnja glukagona, zato to GIP poveava osloboanje glukagona
Undeniably powerful weight loss in a pen and a pill 1-3 Along with diet and exercise Wegovy HD In adults with obesity, Efficacy estimand: ~21% (20.7%) mean weight loss with Wegovy HD (semaglutide) injection 7.2 mg vs 2.4% with placebo at 72 weeks, in an idealized scenario estimating efficacy if all patients remained on treatment and used no other weight-loss therapies* Treatment regimen estimand: ~19% (18.8%) mean weight loss with Wegovy HD vs 3.9% with placebo at 72 weeks, for all patients in the trial regardless of whether patients stayed on treatment or took other weight-loss therapies For adults taking Wegovy for weight reduction: Those who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly

Although not indicated, it may help patients lose some weight and does not increase the risk of major cardiovascular events such as heart attack, stroke or death
any visual change signals potential degradation
This will be an oral agent